Agenus Inc. (AGEN) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Earnings Reports
-
AGEN Q2 2025: $75M Zydus Deal Reshapes Balance Sheet and Accelerates CRC Trial Path
August 27, 2025
-
AGEN Q3 2024: Cash Burn Drops 29% as BotVal Data Drives Strategic Asset Monetization
November 12, 2024
-
AGEN Q1 2024: $100M Royalty Financing Secured, Accelerating Botensilimab Path to Approval
May 07, 2024
-
AGEN Q4 2023: $250M Partner Milestone Sets Stage for Accelerated Oncology Expansion
March 14, 2024